Hohokus, NJ, United States of America

Keith A Yagaloff


Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 34(Granted Patents)


Location History:

  • Bergen, NJ (US) (1993)
  • Hohokus, NJ (US) (1995 - 2003)
  • Broad Brook, CT (US) (2006)

Company Filing History:


Years Active: 1993-2006

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Keith A Yagaloff: Innovator in Melanocortin-4 Receptor Agonist Peptides

Introduction

Keith A Yagaloff is a notable inventor based in Hohokus, NJ (US). He has made significant contributions to the field of biochemistry, particularly in the development of peptides that target the melanocortin-4 receptor (MC4-R). With a total of 5 patents to his name, Yagaloff's work is paving the way for innovative treatments in obesity management.

Latest Patents

Yagaloff's latest patents include groundbreaking work on selective cyclic peptides with melanocortin-4 receptor agonist activity. These peptides, which are cyclized via disulfide or lactam bridges, exhibit agonist activity at the MC4-R and hold promise for treating obesity. Additionally, he has developed selective linear peptides that specifically stimulate MC4 receptor activity, further expanding the potential therapeutic applications of his research.

Career Highlights

Throughout his career, Yagaloff has been associated with Hoffmann-La Roche Inc., a leading global healthcare company. His innovative research has contributed to the advancement of peptide therapeutics, showcasing his expertise in the field.

Collaborations

Yagaloff has collaborated with esteemed colleagues, including Noal Cohen and Ferdinand K Lee, to enhance the scope and impact of his research. Their combined efforts have led to significant advancements in the understanding and application of melanocortin-4 receptor agonists.

Conclusion

Keith A Yagaloff's contributions to the field of peptide research are noteworthy and impactful. His innovative work on melanocortin-4 receptor agonists is set to play a crucial role in the future of obesity treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…